作者
Riemer H. J. A. Slart,Marija Punda,Dalal S Ali,Alberto Bazzocchi,Oliver Bock,Pauline M. Camacho,John Carey,Anita Colquhoun,Juliet Compston,Klaus Engelke,Paola Anna Erba,Nicholas C. Harvey,Diane Krueger,Willem F Lems,E. Michael Lewiecki,Sarah Morgan,Kendall F. Moseley,Christopher F. O’Brien,Linda Probyn,Yumie Rhee,Bradford J. Richmond,John T. Schousboe,Christopher Shuhart,Kate A. Ward,Tim Van den Wyngaert,Jules Zhang-Yin,Aliya Khan
摘要
Abstract The introduction of dual-energy X-ray absorptiometry (DXA) technology in the 1980s revolutionized the diagnosis, management and monitoring of osteoporosis, providing a clinical tool which is now available worldwide. However, DXA measurements are influenced by many technical factors, including the quality control procedures for the instrument, positioning of the patient, and approach to analysis. Reporting of DXA results may be confounded by factors such as selection of reference ranges for T-scores and Z-scores, as well as inadequate knowledge of current standards for interpretation. These points are addressed at length in many international guidelines but are not always easily assimilated by practising clinicians and technicians. Our aim in this report is to identify key elements pertaining to the use of DXA in clinical practice, considering both technical and clinical aspects. Here, we discuss technical aspects of DXA procedures, approaches to interpretation and integration into clinical practice, and the use of non-bone mineral density measurements, such as a vertebral fracture assessment, in clinical risk assessment.